Replimune Group, Inc. - COMMON STOCK (REPL)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
78.4M
Number of holders
99
Total 13F shares, excl. options
35.4M
Shares change
+483K
Total reported value, excl. options
$1.05B
Value change
+$5.53M
Number of buys
42
Number of sells
-49
Price
$29.64

Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2021

117 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q3 2021.
Replimune Group, Inc. - COMMON STOCK (REPL) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35.4M shares of 78.4M outstanding shares and own 45.11% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.72M shares), Omega Fund Management, LLC (4.9M shares), Redmile Group, LLC (4.08M shares), BlackRock Inc. (2.09M shares), STATE STREET CORP (1.61M shares), VANGUARD GROUP INC (1.56M shares), Ensign Peak Advisors, Inc (1.29M shares), LOOMIS SAYLES & CO L P (1.14M shares), FMR LLC (1.05M shares), and EMERALD MUTUAL FUND ADVISERS TRUST (1.02M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.